Exeporfinium chloride (XF-73) nasal gel dosed over 24 hours prior to surgery significantly reduced Staphylococcus aureus nasal carriage in cardiac surgery patients: Safety and efficacy results from a randomized placebo-controlled phase 2 study

Exeporfinium chloride (XF-73) nasal gel dosed over 24 hours prior to surgery significantly reduced Staphylococcus aureus nasal carriage in cardiac surgery patients: Safety and efficacy results from a randomized placebo-controlled phase 2 study

We studied 83 cardiac-surgery patients with nasal S. aureus carriage who received 4 intranasal administrations of XF-73 nasal gel or placebo

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Infection control and hospital epidemiology 2023-07, Vol.44 (7), p.1171-1173
Hauptverfasser: Mangino, Julie E., Firstenberg, Michael S., Milewski, Rita K.C., Rhys-Williams, William, Lees, James P., Dane, Aaron, Love, William G., Gonzalez Moreno, Jesus
Format: Artikel
Sprache:eng
Schlagworte:
Antibiotics
Bone surgery
Clinical trials
Concise Communication
Heart surgery
Infectious diseases
Laboratories
Patients
Skin
Staphylococcus infections
Transplants & implants
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1173
container_issue 7
container_start_page 1171
container_title Infection control and hospital epidemiology
container_volume 44
creator Mangino, Julie E.
Firstenberg, Michael S.
Milewski, Rita K.C.
Rhys-Williams, William
Lees, James P.
Dane, Aaron
Love, William G.
Gonzalez Moreno, Jesus
description We studied 83 cardiac-surgery patients with nasal S. aureus carriage who received 4 intranasal administrations of XF-73 nasal gel or placebo
doi_str_mv 10.1017/ice.2023.17
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10369221</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cupid>10_1017_ice_2023_17</cupid><sourcerecordid>2841738906</sourcerecordid><originalsourceid>FETCH-LOGICAL-c448t-329be2fd748429477f652be04b73456843c860a04c33f67aee0465830e2f49453</originalsourceid><addsrcrecordid>eNptkk1v1DAQhiMEomXhxB2NxKUIZXFsJ056QahqAakSh4LUm-U4k6wrJw52UhH-Nn8AR7ssH-I0luedZzyeN0meZ2SbkUy8MRq3lFC2zcSD5DTL8yotSsYfJqekrKq0pOz2JHkSwh0hRFRV9jg5YUWVZ1zQ0-TH5TccnW_NYOYe9M46bxqEs9urVLBXMKigLHRooXEBG3D36IFy2LnZBxi9cR4mB2H2HfoFgukG0xqthsku4LGZdSy6mdS4W6zTTus5gJo9xrBHa-W9UR2CGdZzY5Q-0kY1GRymcA43qsVpATU0gO3K1ys9zHYK0HrXgwIfk64332O_0SqNtUu1GybvrF2vdiogUAjT3CxPk0etsgGfHeIm-XJ1-fniQ3r96f3Hi3fXqea8nFJGqxpp2wheclpxIdoipzUSXgvG86LkTJcFUYRrxtpCKIypIi8ZiUW84jnbJG_33HGue2x0nMUrK-Ov9cov0ikj_84MZic7dy8zEhdEaRYJZweCd19nDJPsTdBorRrQzUFSURGSxzXTKH35j_Qu7miI80la8kywsiJFVL3eq7R3IXhsj6_JiFzdJKOb5OomGUs2yYs_Bzhqf9knCtIDTvV1NE6Hv7v-D_gTouXZxQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2841738906</pqid></control><display><type>article</type><title>Exeporfinium chloride (XF-73) nasal gel dosed over 24 hours prior to surgery significantly reduced Staphylococcus aureus nasal carriage in cardiac surgery patients: Safety and efficacy results from a randomized placebo-controlled phase 2 study</title><source>ProQuest Central Essentials</source><source>Cambridge Journals Online</source><source>AUTh Library subscriptions: ProQuest Central</source><source>ProQuest Central (Alumni)</source><source>ProQuest Central UK/Ireland</source><creator>Mangino, Julie E. ; Firstenberg, Michael S. ; Milewski, Rita K.C. ; Rhys-Williams, William ; Lees, James P. ; Dane, Aaron ; Love, William G. ; Gonzalez Moreno, Jesus</creator><creatorcontrib>Mangino, Julie E. ; Firstenberg, Michael S. ; Milewski, Rita K.C. ; Rhys-Williams, William ; Lees, James P. ; Dane, Aaron ; Love, William G. ; Gonzalez Moreno, Jesus</creatorcontrib><description>We studied 83 cardiac-surgery patients with nasal S. aureus carriage who received 4 intranasal administrations of XF-73 nasal gel or placebo &lt;24 hours before surgery. One hour before surgery, patients exhibited a S. aureus nasal carriage reduction of 2.5 log10 with XF-73 compared to 0.4 log10 CFU/mL for those who received placebo (95% CI, −2.7 to −1.5; P &lt; .0001).</description><identifier>ISSN: 0899-823X</identifier><identifier>EISSN: 1559-6834</identifier><identifier>DOI: 10.1017/ice.2023.17</identifier><identifier>PMID: 36951472</identifier><language>eng</language><publisher>New York, USA: Cambridge University Press</publisher><subject>Antibiotics ; Bone surgery ; Clinical trials ; Concise Communication ; Heart surgery ; Infectious diseases ; Laboratories ; Patients ; Skin ; Staphylococcus infections ; Transplants &amp; implants</subject><ispartof>Infection control and hospital epidemiology, 2023-07, Vol.44 (7), p.1171-1173</ispartof><rights>Destiny Pharma plc, 2023. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America</rights><rights>Destiny Pharma plc, 2023. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America. This work is licensed under the Creative Commons Attribution License This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited. (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2023 2023 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c448t-329be2fd748429477f652be04b73456843c860a04c33f67aee0465830e2f49453</citedby><cites>FETCH-LOGICAL-c448t-329be2fd748429477f652be04b73456843c860a04c33f67aee0465830e2f49453</cites><orcidid>0000-0001-6755-5025</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2841738906/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2841738906?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>164,230,315,781,785,886,21390,21391,23258,27926,27927,33532,33533,33705,33706,33746,33747,43661,43789,43807,55630,64387,64389,64391,72471,74106,74285,74304</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36951472$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mangino, Julie E.</creatorcontrib><creatorcontrib>Firstenberg, Michael S.</creatorcontrib><creatorcontrib>Milewski, Rita K.C.</creatorcontrib><creatorcontrib>Rhys-Williams, William</creatorcontrib><creatorcontrib>Lees, James P.</creatorcontrib><creatorcontrib>Dane, Aaron</creatorcontrib><creatorcontrib>Love, William G.</creatorcontrib><creatorcontrib>Gonzalez Moreno, Jesus</creatorcontrib><title>Exeporfinium chloride (XF-73) nasal gel dosed over 24 hours prior to surgery significantly reduced Staphylococcus aureus nasal carriage in cardiac surgery patients: Safety and efficacy results from a randomized placebo-controlled phase 2 study</title><title>Infection control and hospital epidemiology</title><addtitle>Infect. Control Hosp. Epidemiol</addtitle><description>We studied 83 cardiac-surgery patients with nasal S. aureus carriage who received 4 intranasal administrations of XF-73 nasal gel or placebo &lt;24 hours before surgery. One hour before surgery, patients exhibited a S. aureus nasal carriage reduction of 2.5 log10 with XF-73 compared to 0.4 log10 CFU/mL for those who received placebo (95% CI, −2.7 to −1.5; P &lt; .0001).</description><subject>Antibiotics</subject><subject>Bone surgery</subject><subject>Clinical trials</subject><subject>Concise Communication</subject><subject>Heart surgery</subject><subject>Infectious diseases</subject><subject>Laboratories</subject><subject>Patients</subject><subject>Skin</subject><subject>Staphylococcus infections</subject><subject>Transplants &amp; implants</subject><issn>0899-823X</issn><issn>1559-6834</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>IKXGN</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNptkk1v1DAQhiMEomXhxB2NxKUIZXFsJ056QahqAakSh4LUm-U4k6wrJw52UhH-Nn8AR7ssH-I0luedZzyeN0meZ2SbkUy8MRq3lFC2zcSD5DTL8yotSsYfJqekrKq0pOz2JHkSwh0hRFRV9jg5YUWVZ1zQ0-TH5TccnW_NYOYe9M46bxqEs9urVLBXMKigLHRooXEBG3D36IFy2LnZBxi9cR4mB2H2HfoFgukG0xqthsku4LGZdSy6mdS4W6zTTus5gJo9xrBHa-W9UR2CGdZzY5Q-0kY1GRymcA43qsVpATU0gO3K1ys9zHYK0HrXgwIfk64332O_0SqNtUu1GybvrF2vdiogUAjT3CxPk0etsgGfHeIm-XJ1-fniQ3r96f3Hi3fXqea8nFJGqxpp2wheclpxIdoipzUSXgvG86LkTJcFUYRrxtpCKIypIi8ZiUW84jnbJG_33HGue2x0nMUrK-Ov9cov0ikj_84MZic7dy8zEhdEaRYJZweCd19nDJPsTdBorRrQzUFSURGSxzXTKH35j_Qu7miI80la8kywsiJFVL3eq7R3IXhsj6_JiFzdJKOb5OomGUs2yYs_Bzhqf9knCtIDTvV1NE6Hv7v-D_gTouXZxQ</recordid><startdate>20230701</startdate><enddate>20230701</enddate><creator>Mangino, Julie E.</creator><creator>Firstenberg, Michael S.</creator><creator>Milewski, Rita K.C.</creator><creator>Rhys-Williams, William</creator><creator>Lees, James P.</creator><creator>Dane, Aaron</creator><creator>Love, William G.</creator><creator>Gonzalez Moreno, Jesus</creator><general>Cambridge University Press</general><scope>IKXGN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>S0X</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-6755-5025</orcidid></search><sort><creationdate>20230701</creationdate><title>Exeporfinium chloride (XF-73) nasal gel dosed over 24 hours prior to surgery significantly reduced Staphylococcus aureus nasal carriage in cardiac surgery patients: Safety and efficacy results from a randomized placebo-controlled phase 2 study</title><author>Mangino, Julie E. ; Firstenberg, Michael S. ; Milewski, Rita K.C. ; Rhys-Williams, William ; Lees, James P. ; Dane, Aaron ; Love, William G. ; Gonzalez Moreno, Jesus</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c448t-329be2fd748429477f652be04b73456843c860a04c33f67aee0465830e2f49453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Antibiotics</topic><topic>Bone surgery</topic><topic>Clinical trials</topic><topic>Concise Communication</topic><topic>Heart surgery</topic><topic>Infectious diseases</topic><topic>Laboratories</topic><topic>Patients</topic><topic>Skin</topic><topic>Staphylococcus infections</topic><topic>Transplants &amp; implants</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mangino, Julie E.</creatorcontrib><creatorcontrib>Firstenberg, Michael S.</creatorcontrib><creatorcontrib>Milewski, Rita K.C.</creatorcontrib><creatorcontrib>Rhys-Williams, William</creatorcontrib><creatorcontrib>Lees, James P.</creatorcontrib><creatorcontrib>Dane, Aaron</creatorcontrib><creatorcontrib>Love, William G.</creatorcontrib><creatorcontrib>Gonzalez Moreno, Jesus</creatorcontrib><collection>Cambridge University Press Wholly Gold Open Access Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Family Health Database (Proquest)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest Health Management</collection><collection>PML(ProQuest Medical Library)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Infection control and hospital epidemiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mangino, Julie E.</au><au>Firstenberg, Michael S.</au><au>Milewski, Rita K.C.</au><au>Rhys-Williams, William</au><au>Lees, James P.</au><au>Dane, Aaron</au><au>Love, William G.</au><au>Gonzalez Moreno, Jesus</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Exeporfinium chloride (XF-73) nasal gel dosed over 24 hours prior to surgery significantly reduced Staphylococcus aureus nasal carriage in cardiac surgery patients: Safety and efficacy results from a randomized placebo-controlled phase 2 study</atitle><jtitle>Infection control and hospital epidemiology</jtitle><addtitle>Infect. Control Hosp. Epidemiol</addtitle><date>2023-07-01</date><risdate>2023</risdate><volume>44</volume><issue>7</issue><spage>1171</spage><epage>1173</epage><pages>1171-1173</pages><issn>0899-823X</issn><eissn>1559-6834</eissn><abstract>We studied 83 cardiac-surgery patients with nasal S. aureus carriage who received 4 intranasal administrations of XF-73 nasal gel or placebo &lt;24 hours before surgery. One hour before surgery, patients exhibited a S. aureus nasal carriage reduction of 2.5 log10 with XF-73 compared to 0.4 log10 CFU/mL for those who received placebo (95% CI, −2.7 to −1.5; P &lt; .0001).</abstract><cop>New York, USA</cop><pub>Cambridge University Press</pub><pmid>36951472</pmid><doi>10.1017/ice.2023.17</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0001-6755-5025</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0899-823X
ispartof Infection control and hospital epidemiology, 2023-07, Vol.44 (7), p.1171-1173
issn 0899-823X
1559-6834
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10369221
source ProQuest Central Essentials; Cambridge Journals Online; AUTh Library subscriptions: ProQuest Central; ProQuest Central (Alumni); ProQuest Central UK/Ireland
subjects Antibiotics
Bone surgery
Clinical trials
Concise Communication
Heart surgery
Infectious diseases
Laboratories
Patients
Skin
Staphylococcus infections
Transplants & implants
title Exeporfinium chloride (XF-73) nasal gel dosed over 24 hours prior to surgery significantly reduced Staphylococcus aureus nasal carriage in cardiac surgery patients: Safety and efficacy results from a randomized placebo-controlled phase 2 study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T17%3A51%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Exeporfinium%20chloride%20(XF-73)%20nasal%20gel%20dosed%20over%2024%20hours%20prior%20to%20surgery%20significantly%20reduced%20Staphylococcus%20aureus%20nasal%20carriage%20in%20cardiac%20surgery%20patients:%20Safety%20and%20efficacy%20results%20from%20a%20randomized%20placebo-controlled%20phase%202%20study&rft.jtitle=Infection%20control%20and%20hospital%20epidemiology&rft.au=Mangino,%20Julie%20E.&rft.date=2023-07-01&rft.volume=44&rft.issue=7&rft.spage=1171&rft.epage=1173&rft.pages=1171-1173&rft.issn=0899-823X&rft.eissn=1559-6834&rft_id=info:doi/10.1017/ice.2023.17&rft_dat=%3Cproquest_pubme%3E2841738906%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2841738906&rft_id=info:pmid/36951472&rft_cupid=10_1017_ice_2023_17&rfr_iscdi=true